Wird geladen...

Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease

Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 and March 2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Matsumoto, Satohiro, Mashima, Hirosato
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747557/
https://ncbi.nlm.nih.gov/pubmed/33335169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79207-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!